Weidong Jia

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Top Venues

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Junru Feng, Hui Lu, Wenhao Ma, Wenjing Tian, Zhuan Lu, Hongying Yang, Yongping Cai, Pengfei Cai, Yuchen Sun, Zilong Zhou, Jiaqian Feng, Jiazhong Deng, Ying Shu, Kun Qu, Weidong Jia, Ping Gao, Huafeng Zhang
Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. Protein & cell 13 (11) (2022)
Huafeng Zhang, Chenchen Li, Chuanzhen Hu, Qian Wu, Yongping Cai, Songge Xing, Hui Lu, Lin Wang, De Huang, Linchong Sun, Tingting Li, Xiaoping He, Xiuying Zhong, Junfeng Wang, Ping Gao, Zachary J Smith, Weidong Jia, Huafeng Zhang
Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP-1. EMBO reports 20 (10) (2019)
Xin Chen, Yazhou Zhang, Nu Zhang, Yongsheng Ge, Weidong Jia
Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report. OncoTargets and therapy 12 (2019)